-
2
-
-
0026099489
-
VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients
-
Boccadoro M, Marmont F, Tribalto M et al VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients. J Clin Oncol 1991; 9: 444-448.
-
(1991)
J Clin Oncol
, vol.9
, pp. 444-448
-
-
Boccadoro, M.1
Marmont, F.2
Tribalto, M.3
-
3
-
-
0020578180
-
High-dose intravenous melphalan for plasma-cell leukemia and myeloma
-
McElwain TJ, Powles R. High-dose intravenous melphalan for plasma-cell leukemia and myeloma. Lancet 1983; 2: 822-824.
-
(1983)
Lancet
, vol.2
, pp. 822-824
-
-
McElwain, T.J.1
Powles, R.2
-
4
-
-
0024255829
-
Prognostic factors with high-dose melphalan for refractory multiple myeloma
-
Barlogie B, Alexanian R, Smallwood L et al. Prognostic factors with high-dose melphalan for refractory multiple myeloma. Blood 1988; 72: 2015-2019.
-
(1988)
Blood
, vol.72
, pp. 2015-2019
-
-
Barlogie, B.1
Alexanian, R.2
Smallwood, L.3
-
5
-
-
0025148754
-
High-dose melphalan and GM-CSF for refractory multiple myeloma
-
Barlogie B, Jagannath S, Dixon D et al. High-dose melphalan and GM-CSF for refractory multiple myeloma. Blood 1990; 76: 677-680.
-
(1990)
Blood
, vol.76
, pp. 677-680
-
-
Barlogie, B.1
Jagannath, S.2
Dixon, D.3
-
6
-
-
0022510876
-
High-dose melphalan with autologous bone marrow transplantation for multiple myeloma
-
Barlogie B, Hall R, Zander A et al. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 1986; 67: 1298-1301.
-
(1986)
Blood
, vol.67
, pp. 1298-1301
-
-
Barlogie, B.1
Hall, R.2
Zander, A.3
-
7
-
-
0023552805
-
High dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma
-
Barlogie B, Alexanian R. Dicke K et al. High dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 1987; 70: 869-872.
-
(1987)
Blood
, vol.70
, pp. 869-872
-
-
Barlogie, B.1
Alexanian, R.2
Dicke, K.3
-
8
-
-
0025203141
-
Autologous bone mar- Row transplantation in multiple myeloma: Identification of prognostic factors
-
Jagannath S, Barlogie B, Dicke K et al. Autologous bone mar- row transplantation in multiple myeloma: identification of prognostic factors. Blood 1990; 76: 1860-1866.
-
(1990)
Blood
, vol.76
, pp. 1860-1866
-
-
Jagannath, S.1
Barlogie, B.2
Dicke, K.3
-
9
-
-
0028344647
-
High-dose melphalan for multiple myeloma: Long-term follow-up data
-
Cunningham D, Paz-Ares ME. Gore ME et al. High-dose melphalan for multiple myeloma: long-term follow-up data. J Clin Oncol 1994; 12: 764-768.
-
(1994)
J Clin Oncol
, vol.12
, pp. 764-768
-
-
Cunningham, D.1
Paz-Ares, M.E.2
Gore, M.E.3
-
10
-
-
0028194968
-
High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma
-
Cunningham D. Paz-Ares L, Milan S et al. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol 1994; 12. 759-763.
-
(1994)
J Clin Oncol
, vol.12
, pp. 759-763
-
-
Cunningham, D.1
Paz-Ares, L.2
Milan, S.3
-
11
-
-
0027496486
-
Monoclonal anti-body-purged bone marrow transplantation therapy for multiple myeloma
-
Anderson KC, Andersen J, Soiffer R et al. Monoclonal anti-body-purged bone marrow transplantation therapy for multiple myeloma. Blood 1993; 82: 2568-2576.
-
(1993)
Blood
, vol.82
, pp. 2568-2576
-
-
Anderson, K.C.1
Andersen, J.2
Soiffer, R.3
-
12
-
-
9244263575
-
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma
-
Bensinger WI, Rowley SD, Demirer T et al. High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. J Clin Oncol 1996; 14: 1447-1456.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1447-1456
-
-
Bensinger, W.I.1
Rowley, S.D.2
Demirer, T.3
-
13
-
-
0029166629
-
Autologous stem cell transplantation in multiple myeloma: Results of the European group for bone marrow transplantation
-
Bjorkstrand B, Ljungman P, Bird JM et al. Autologous stem cell transplantation in multiple myeloma: results of the European group for bone marrow transplantation. Stem Cells 1995; 13 (Suppl. 2): 140-146.
-
(1995)
Stem Cells
, vol.13
, Issue.SUPPL. 2
, pp. 140-146
-
-
Bjorkstrand, B.1
Ljungman, P.2
Bird, J.M.3
-
14
-
-
0029035095
-
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma; a report of the French registry on autologous transplantation in multiple myeloma
-
Harousseau J, Attal M, Divine M et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma; a report of the French registry on autologous transplantation in multiple myeloma. Blood 1995; 85: 3077-3085.
-
(1995)
Blood
, vol.85
, pp. 3077-3085
-
-
Harousseau, J.1
Attal, M.2
Divine, M.3
-
16
-
-
0016804136
-
A clinical staging system for multiple myeloma
-
Durie BGM, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842-854.
-
(1975)
Cancer
, vol.36
, pp. 842-854
-
-
Durie, B.G.M.1
Salmon, S.E.2
-
17
-
-
0020656085
-
Long-term survival in multiple myeloma
-
Kyle RA. Long-term survival in multiple myeloma. New Engl J Med 1983; 308: 314-316.
-
(1983)
New Engl J Med
, vol.308
, pp. 314-316
-
-
Kyle, R.A.1
-
18
-
-
0022357528
-
Ten year survival in multiple myeloma
-
Alexanian R. Ten year survival in multiple myeloma. Arch Intern Med 1985; 145: 2073-2074.
-
(1985)
Arch Intern Med
, vol.145
, pp. 2073-2074
-
-
Alexanian, R.1
-
19
-
-
0026733455
-
Low risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
-
Jagannath S, Vesole DH, Glenn L et al. Low risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992; 80: 1666-1672.
-
(1992)
Blood
, vol.80
, pp. 1666-1672
-
-
Jagannath, S.1
Vesole, D.H.2
Glenn, L.3
-
20
-
-
0028335814
-
High-dose therapy for refractory multiple myeloma: Improved prognosis with better supportive care and double transplants
-
Vesole DH, Barlogie B, Jagannath S et al. High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants. Blood 1994; 84: 950-956.
-
(1994)
Blood
, vol.84
, pp. 950-956
-
-
Vesole, D.H.1
Barlogie, B.2
Jagannath, S.3
-
21
-
-
0344813041
-
Autotransplants in multiple myeloma: What have we learned?
-
Vesole DH, Tricot G, Jagannath S et al. Autotransplants in multiple myeloma: what have we learned? Blood 1996; 88: 838-847.
-
(1996)
Blood
, vol.88
, pp. 838-847
-
-
Vesole, D.H.1
Tricot, G.2
Jagannath, S.3
-
22
-
-
8944220233
-
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
-
Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New Engl J Med 1996; 335: 91-97.
-
(1996)
New Engl J Med
, vol.335
, pp. 91-97
-
-
Attal, M.1
Harousseau, J.L.2
Stoppa, A.M.3
-
23
-
-
0031001279
-
Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
-
Barlogie B, Jagannath S, Vesole DH et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789-793.
-
(1997)
Blood
, vol.89
, pp. 789-793
-
-
Barlogie, B.1
Jagannath, S.2
Vesole, D.H.3
-
24
-
-
0345503577
-
Total therapy (TT) with tandem autotransplants (2 TX) for 231 newly diagnosed patients (PTS) with multiple myeloma (MM)
-
Abstr. 685a
-
Jagannath S, Tricot G, Vesole D et al. Total therapy (TT) with tandem autotransplants (2 TX) for 231 newly diagnosed patients (PTS) with multiple myeloma (MM). Blood 1996; 88: 10 (Abstr. 685a).
-
(1996)
Blood
, vol.88
, pp. 10
-
-
Jagannath, S.1
Tricot, G.2
Vesole, D.3
|